September 23, 2020 01:35 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India, China agree to stop sending more troops to frontline in Ladakh | Time to separate interests from Tata Group, says Mistry family | Facebook India moves SC against Delhi Assembly Panel's notice | Mamata government wants to enroll for PM-Kisan, Ayushman Bharat if funds routed through state | Yogi Adityanath government in UP unveils plan to set up Film City

Lupin launches generic Aricept tablets in the US

India blooms News Service | | 31 Mar 2016, 03:53 pm
Mumbai/ Baltimore, Mar 31 (IBNS) Mumbai-based Lupin Limited (Lupin), a transnational pharmaceutical company producing and developing a wide range of branded and generic formulations, biotechnology products and APIs globally, announced on Thursday that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Donepezil Hydrochloride Tablets, 23 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic equivalent of Eisai Inc's Aricept® Tablets, 23mg.
Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. works in the area of generic medicines and branded formulations.
Lupin's Donepezil Hydrochloride Tablets, 23 mg are the AB rated generic equivalent of Eisai Inc's Aricept® Tablets, 23mg. It is indicated for the treatment of dementia of the Alzheimer's type.
Aricept® had US sales of USD 47.1 million (IMS MAT December 2015).